Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs
Nessun attività
Corporate debt securities
Below is the list of Eli Lilly & Co Shs Cert Deposito Arg Repr 0.14285714 Shs bonds, sorted by yield to maturity. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
|---|---|---|---|---|---|---|---|---|---|
| 5,65% | 44 K | 88,40% | 4,650% | 2044-06-15 | 38,34 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,64% | 0 | 55,65% | 1,625% | 2043-09-14 | 250 M GBP | 1.000,00 GBP | 100.000,00 GBP | Eli Lilly & Co. | |
| 5,56% | 4,2 M | 101,34% | 5,650% | 2065-10-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,56% | 1,8 M | 100,57% | 5,600% | 2065-02-12 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,55% | 50 K | 94,37% | 5,200% | 2064-08-14 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,55% | 8,71 M | 92,83% | 5,100% | 2064-02-09 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,53% | 2,52 M | 90,78% | 4,950% | 2063-02-27 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,53% | 0 | 79,05% | 4,150% | 2059-03-15 | 591,29 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,47% | 9,36 M | 101,12% | 5,550% | 2055-10-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,46% | 599 K | 100,50% | 5,500% | 2055-02-12 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,45% | 5,72 M | 94,14% | 5,050% | 2054-08-14 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,45% | 0 | 80,30% | 3,950% | 2049-03-15 | 958,15 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,45% | 1,2 M | 91,83% | 4,875% | 2053-02-27 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,45% | 0 | 81,19% | 3,950% | 2047-05-15 | 346,95 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,45% | 0 | 57,10% | 2,250% | 2050-05-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,44% | 388 K | 93,67% | 5,000% | 2054-02-09 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,42% | 0 | 54,45% | 2,500% | 2060-09-15 | 850 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,25% | 43 K | 99,94% | 5,000% | 2026-02-27 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,25% | 0 | 86,99% | 3,875% | 2039-03-15 | 240,25 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,22% | 966 K | 80,47% | 3,700% | 2045-03-01 | 386,8 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 5,01% | 30 K | 113,74% | 6,770% | 2036-01-01 | 158,56 M USD | 1.000,00 USD | 1.000,00 USD | Eli Lilly & Co. | |
| 4,71% | 75 K | 110,56% | 5,950% | 2037-11-15 | 266,83 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,64% | 340 K | 101,95% | 4,900% | 2035-10-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,60% | 175 K | 103,53% | 5,100% | 2035-02-12 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,55% | 5,7 M | 108,73% | 5,550% | 2037-03-15 | 444,73 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,51% | 314 K | 100,62% | 4,600% | 2034-08-14 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,47% | 309 K | 101,53% | 4,700% | 2034-02-09 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,43% | 0 | 45,58% | 1,375% | 2061-09-14 | 700 M EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 4,31% | 195 K | 102,36% | 4,700% | 2033-02-27 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,29% | 0 | 51,19% | 1,125% | 2051-09-14 | 500 M EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 4,24% | 3,64 M | 101,81% | 4,550% | 2032-10-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,21% | 285 K | 103,70% | 4,900% | 2032-02-12 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 4,19% | 0 | 62,89% | 1,700% | 2049-11-01 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 4,09% | 5,27 M | 100,72% | 4,250% | 2031-03-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,99% | 4,27 M | 102,86% | 4,750% | 2030-02-12 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,89% | 0 | 98,45% | 3,375% | 2029-03-15 | 930,56 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,88% | 21,28 M | 101,10% | 4,200% | 2029-08-14 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,85% | 760 K | 101,90% | 4,500% | 2029-02-09 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,79% | 0 | 99,09% | 3,100% | 2027-05-15 | 401,45 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,74% | 10,6 M | 100,65% | 4,000% | 2028-10-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,74% | 1,6 M | 100,87% | 4,500% | 2027-02-09 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,69% | 1,6 M | 102,18% | 5,500% | 2027-03-15 | 364,32 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,67% | 322 K | 101,79% | 4,550% | 2028-02-12 | 1 B USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,65% | 1,3 M | 100,82% | 4,150% | 2027-08-14 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. | |
| 3,21% | 0 | 81,69% | 0,500% | 2033-09-14 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 3,00% | 0 | 87,40% | 0,625% | 2031-11-01 | 600 M EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 2,76% | 0 | 97,35% | 2,125% | 2030-06-03 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 2,29% | 0 | 99,70% | 1,625% | 2026-06-02 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Eli Lilly & Co. | |
| 0,65% | 0 | 99,53% | 0,450% | 2028-05-24 | 400 M CHF | 5.000,00 CHF | 5.000,00 CHF | Eli Lilly & Co. | |
| — | 1,54 M | 100,89% | 4,702% | 2028-10-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | Eli Lilly & Co. |